Literature DB >> 7472883

Gnathostoma spinigerum: growth and development of third-stage larvae in vitro.

W Maleewong1, P M Intapan, J Khempila, S Wongwajana, C Wongkham, N Morakote.   

Abstract

Advanced third-stage larvae of Gnathostoma spinigerum were cultured in RPMI-1640, with various supplements at 37 C under 5% CO2 in air for 300 days. The most suitable medium supplement for worm development was 10% fetal calf serum, 1% dog serum, and 0.25% dog hemolysate. After approximately 180 days of cultivation, some larvae molted to the fourth stage as distinguished by 8 transverse rows of cephalic hooklets and well differentiated sex organs. The maximum body length and width of these larvae were 18.6 mm and 1.1 mm, respectively. Six of 50 larvae (12%) developed to the fourth stage, with a 32% survival rate at the end of cultivation. Although the highest survival rate (70%) of the worms was observed in the medium supplemented with 25 mM NaHCO3, only 4% developed into fourth stage larvae. The addition of fetal calf serum, dog serum, and dog hemolysate was essential for growth and development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7472883

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  2 in total

1.  Ultrastructural changes in the advanced third larval stage of Gnathostoma binucleatum Almeyda-Artigas, 1991 (Nematoda: Spirurida) following albendazole and albendazole sulfoxide in vitro exposure.

Authors:  Alejandro Cruz-Reyes; Bertha Gloria Ortega-Corona; Armando Zepeda-Rodríguez; Armando Pérez-Torres
Journal:  Parasitol Res       Date:  2011-07-09       Impact factor: 2.289

2.  Protein and antigen profiles of third-stage larvae of Gnathostoma spinigerum assessed with next-generation sequencing transcriptomic information.

Authors:  Kathyleen Nogrado; Tipparat Thiangtrongjit; Poom Adisakwattana; Paron Dekumyoy; Sant Muangnoicharoen; Charin Thawornkuno; Onrapak Reamtong
Journal:  Sci Rep       Date:  2022-04-28       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.